Trimitra Prawara Goldland Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Trimitra Prawara Goldland Tbk. trades at Rp555 (market cap 557.5B, 4.54M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B, 12.18M 24h volume). The key difference: Trimitra Prawara Goldland Tbk. is far larger — about 3.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (12.18M versus 4.54M). Which is the better fit depends on your goals.
| ATAP | DKHH | |
|---|---|---|
Market Cap | 557.5B | 160.67B |
Volume | 4.54M | 12.18M |
Lot | 45.39K | 121.83K |
Turnover | 2.47B | 762.52M |
Average Price | 543.8 | 62.59 |
Value | 2.47B | 762.52M |
Indicative Equilibrium Price | 555 | 63 |
Indicative Equilibrium Volume | 104 | 2.19K |
Trailing returns across standard periods
Latest headlines on both assets
PT Trimitra Prawara Goldland Tbk (the Company) was established in Indonesia based on Notarial Deed No. 13 of Dede Munajat, S.H., on March 23, 2015 a Notary in Bogor. The Company started its commercial operations in 2015.
Read more on ATAP →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →